- 10:46 PM Astec LifeSciences to start a project in Q3FY11
- 09:24 PM Student visa applications to US, UK see 25% drop
- 09:11 PM US to face stimulus aftershocks: Warren Buffett
- 09:02 PM Expert stock/sector picks for tricky markets
- 08:52 PM Expert stock/sector picks in these markets
- 08:20 PM India to sell $70 bn shares in 3 years: Morgan...
- 08:18 PM November 26: Events to watch out for
- 07:40 PM ITC rules out hostile takeover of East India Hotel...
- 07:34 PM Godrej, Marico eye UK-based skincare brand Simple:...
- 07:31 PM Sugar mills to make historic profits of Rs 7/kg th...



Dishman Pharmaceuticals and Chemicals Limited (Dishman) is pleased to announce that it has successfully completed US FDA inspection for its facility located at Bavla, which is a 100% EOU, to manufacture Eprosartan Mesylate, an anti hyper-tension drug, to be supplied to Solvay Pharmaceuticals, BV, a fortune 500 company.
Dishman is one of the two companies in the world with whom Solvay hasentered into a long-term agreement for supply of newly developed molecule,whose patent is to expire in 2013.
With this event, Solvay will source its requirements for US markets from Dishman. Solvay has increased the quantity of Eprosartan Mesylate to be supplied by Dishman by 50%.
Eprosartan Mesylate is produced from three Starting Materials, whose process technology was developed by Dishman at its R & D, and Solvay having recognized the efforts put in by Dishman in this development has entered into long-term Agreement to procure these Starting Materials to manufacture Eprosartan Mesylate by the second supplier from whom Solvay is outsourcing its balance requirement of Eprosartan Mesylate.
Sourced From : Sobhagya Advertising Service
|
|
Business
Business News | Economy | Earnings | BSE NSE Notices
General News
Current Affairs | Politics | World News | Sports | Entertainment
Corporate Strategy
Management | Advertising | Marketing | Legal
Personal Finance
Tax | Insurance | Credit Cards | Loans | Property | Retirement | Investment Help | Financial Planning | Fixed Income
Markets
Local Market | Global Market | Market Cues | Analysis | Expert & FII outlook | Brokerage Recomendation
Stocks
Stocks in News | Expert Advice | ADRs & GDRs | IPO
Mutual Funds
News | Advice | MF Analysis | Fund Managers Views
Lifestyle
Travel | Wellness | Technology | Auto| Books
-
Most Read
-
Most Viewed
- 10 Companies that FIIs love
- 10 companies that MF managers love
- Ex-bonus, RIL will see correction: SP Tulsian

- Sudarshan Sukhani's top five picks for today's trade

- Mkts to remain strong; bet on midcaps: Ramesh Damani
- Nifty to test 5500 post 5-7% correction: JM Financial

- Ganeshaspeaks: Market prediction for Nov 25
- Expert sector picks to power your portfolio ahead

- Below Rs 94, Mahindra Satyam can test Rs 85: Bhambwani

- Mah Satyam looks at out-of-court settlement with creditors

- S&P raises fears over health of some banks
Source: ft.com
- Auto sector growth to push up demand for rubber
Source: Business Line
- High networth individuals see glitter in commodities
Source: Business Line
- Tatas may launch electric Indica by early 2011
Source: Business Line










